Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia.
D000380:Agranulocytosis / Q000150:complications*; D001419:Bacteria / Q000187:drug effects; D002228:Carbenicillin / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology / Q000633:toxicity; D004357:Drug Synergism; D005334:Fever / Q000150:complications; D005839:Gentamicins / Q000008:administration & dosage* / Q000097:blood / Q000494:pharmacology / Q000633:toxicity; D006801:Humans; D007239:Infections / Q000188:drug therapy* / Q000382:microbiology; D007710:Klebsiella Infections / Q000188:drug therapy; D007938:Leukemia / Q000150:complications; D008826:Microbial Sensitivity Tests; D009369:Neoplasms / Q000150:complications*; D010406:Penicillins / Q000008:administration & dosage*; D011552:Pseudomonas Infections / Q000188:drug therapy; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D018805:Sepsis / Q000188:drug therapy
D005839:Gentamicins; D010406:Penicillins; D002228:Carbenicillin